To participate, please dial one of the following numbers and ask to join the Verona Pharma call: A live webcast will be available on the Events and Presentations link on the Investors page of the ...

We've identified the following companies as similar to Verona Pharma PLC ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...

Highlights,Sei Investments Co. reduced its position in Verona Pharma during the fourth quarter.,Other institutional entities, including GAMMA Investing LLC and Diversify Advisory Services LLC, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We continue to deliver strong and growing value to our shareholders and investor community." Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Paolo Zanetti Formation: 3 - 5 - 2 Manager: Cristian Chivu Formation ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...